The fungal infection mucormycosis is caused by a group of related fungi, the 1 6 8 mouse were able to acquire FK506 resistance over the short time period of incubation 1 6 9
( Fig 2B) . Quantification of FK506 resistance was performed with a target number of 150 1 7 0 patched colonies from each organ condition; fewer colonies were used if less than 150 1 7 1 colonies were recovered from the organ homogenate (Table S1 ). Representative sensitive and resistant isolates were selected for further analysis hybridization revealed that all resistant strains expressed sRNAs against the fkbA gene, as would be expected if they had maintained their resistance through epimutation (Fig   1  7  7 2C). Strains which had reverted to sensitivity, regardless of organ of origin, no longer 1 7 8 expressed sRNAs against fkbA (Fig 2C) . days prior to infection. In this model, the mice are euthanized after two days due to a 1 8 3 more rapid course of infection; however, the brain-specific reversion of epimutation is 1 8 4 maintained (Fig S1A, C) . Similarly, analysis of representative sensitive and resistant
isolates from all organs revealed that the phenotypic loss of FK506 resistance was 1 8 6 correlated with the cessation of sRNA expression against fkbA (Fig S1B) . Infection with 1 8 7 1006PhL in this model also does not lead to the development of FK506 resistance from 1 8 8 the recovered wild-type isolates. In vivo passage causes development of fkbA epimutants in an organ-1 9 1 specific fashion after prolonged FK506 exposure. In vivo passage in mice without 1 9 2 drug exposure does not lead to direct induction of epimutation-based FK506 resistance. However, passage through a murine host does lead to increased rates of epimutation if 1 9 4 recovered strains are exposed to FK506 for longer periods of time. As in previous experiments, immunocompetent mice were retroorbitally infected 1 9 7
with wild-type 1006PhL spores and euthanized after four days when moribund. Organ homogenates from three mice were plated directly on YPD + antibiotics + FK506, as were 1006PhL spores that did not undergo in vivo passage. Plates were incubated at seen with isolates from the brain (Fig 3A) . In this case, brain-derived isolates developed 2 0 5 FK506 resistance at an average rate of 6.5%, higher than the rate observed in isolates 2 0 6 from any other organ or from spores which did not undergo in vivo passage. representative FK506-sensitive and -resistant strains from each mouse (Fig 3B) . More passage. The overall rate of FK506 resistance was much lower in strains derived from 2 1 3 the liver, spleen, kidney, or lung, or in spores which did not undergo in vivo passage; however, the predominant mechanism of resistance in these isolates was still sRNA- against fkbA (Fig 3B) . in the brain than in the other organs studied (Fig 1C) . Alternatively, instead of merely 2 4 5 serving as a location for growth, the brain environment could provide a key, unidentified 2 4 6 facet that induces epimutant switching. The rapid reversion effect was not replicated in 2 4 7 vitro using commercially available media made from specific organs (tested using the This is the first example in which a stressful environmental condition -exposure 2 6 6 to the host brain -has led to increased rates of epimutation in wild-type Mucor.
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Previously tested conditions which did not increase rates of epimutation included prior which were reverted to wild type), antifungal drug exposure, cell wall stress, low
nitrogen, low glucose, oxidative stress, and trisporic acid (mating conditions). The only 2 7 1 described method which had increased the rate of epimutation was mutation of 2 7 2 components of the core RNAi pathway (17). We have unsuccessfully attempted to 2 7 3 replicate this brain-specific induction by testing various pH and hypoxia conditions (Z. Chang, unpublished data); additional study is required to elucidate the factor(s) that
lead to this increased rate of resistance. Given that Mucor is an environmentally ubiquitous fungus encountered on a 2 7 8 global scale (28), it is also worthwhile to consider how non-host-pathogen interactions in 2 7 9 the soil environment might affect traits such as epimutation. Epimutation is not limited to In summary, this study of epimutation revealed that epimutations affecting 2 9 3 antifungal resistance can be both induced and reverted over the course of in vivo Mucor can be found, from soil to invertebrate to vertebrate hosts. A better 2 9 7 understanding of the mechanisms by which fungi can adapt to antifungal stress will 2 9 8 improve our understanding of fungal biology and pathogenesis, while opening potential avenues for clinical treatment. Pharma) was sterilely added to YPD media as required after autoclaving, to achieve a 20% of starting body weight, or significant loss of grooming or mobility).
All intravenous infections were performed via retroorbital injection unless
otherwise noted, an approach developed based on previously published protocols (23). To perform retroorbital injections, mice were anesthetized by exposure to inhaled isoflurane. Fungal inoculum suspended in PBS was then injected behind either the right 1 7
As needed, mice were immunosuppressed two days prior to fungal infection. A dissected. Whole organs were homogenized in 1 mL of sterile PBS through bead homogenates were plated on YPD agar containing antibiotics (50 µg/ml ampicillin and
30 µg/ml chloramphenicol) for selective isolation of fungal colonies.
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When hypoxic conditions were required, the GasPak EZ Container System was Incubation Chamber and three anaerobe satchets were added prior to sealing the 3 3 9
chamber. Maintenance of hypoxic conditions (less than 1% O 2 and greater than 13% 3 4 0 CO 2 ) was monitored using Dry Anaerobic Indicator Strips (BD). were picked for further analysis. not produce a quantitative total for fungal burden in organs, due to the breakup of hyphae into fragments during the bead beating step; however, the resulting counts allow promotes mRNA degradation in basal fungi. PLoS Genet 11:e1005168. 17. Calo S, Shertz-Wall C, Lee SC, Bastidas RJ, Nicolas FE, Granek JA,
Mieczkowski P, Torres-Martinez S, Ruiz-Vazquez RM, Cardenas ME, Heitman J. Nature 513:555-8. GMS (Gomori Methenamine-Silver) reveals abundant fungal elements. recovered from multiple organs after in vivo infection/passage in one mouse each.
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Strains were recovered after mouse was moribund, four days post infection. SCV522, 5 0 9 fkbA epimutant; 1006PhL, wild-type strain; R, resistant strain; S, sensitive strain. A. Kidney-R2 Lung-R1 Brain-S1 Brain-S2 Liver-S1 Liver-S2 Spleen-S1 Kidney-S1 Kidney-S2 Brain-S1 Brain-S1 Brain-S1 
